These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 30205750)

  • 1. Quality control guidelines for clinical-grade human induced pluripotent stem cell lines.
    Sullivan S; Stacey GN; Akazawa C; Aoyama N; Baptista R; Bedford P; Bennaceur Griscelli A; Chandra A; Elwood N; Girard M; Kawamata S; Hanatani T; Latsis T; Lin S; Ludwig TE; Malygina T; Mack A; Mountford JC; Noggle S; Pereira LV; Price J; Sheldon M; Srivastava A; Stachelscheid H; Velayudhan SR; Ward NJ; Turner ML; Barry J; Song J
    Regen Med; 2018 Oct; 13(7):859-866. PubMed ID: 30205750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Report from a Workshop of the International Stem Cell Banking Initiative, Held in Collaboration of Global Alliance for iPSC Therapies and the Harvard Stem Cell Institute, Boston, 2017.
    Kim JH; Alderton A; Crook JM; Benvenisty N; Brandsten C; Firpo M; Harrison PW; Kawamata S; Kawase E; Kurtz A; Loring JF; Ludwig T; Man J; Mountford JC; Turner ML; Oh S; da Veiga Pereira L; Pranke P; Sheldon M; Steeg R; Sullivan S; Yaffe M; Zhou Q; Stacey GN
    Stem Cells; 2019 Sep; 37(9):1130-1135. PubMed ID: 31021472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Illustrating the potency of current Good Manufacturing Practice-compliant induced pluripotent stem cell lines as a source of multiple cell lineages using standardized protocols.
    Rao MS; Pei Y; Garcia TY; Chew S; Kasai T; Hisai T; Taniguchi H; Takebe T; Lamba DA; Zeng X
    Cytotherapy; 2018 Jun; 20(6):861-872. PubMed ID: 29793831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quality Assurance in Stem Cell Banking: Emphasis on Embryonic and Induced Pluripotent Stem Cell Banking.
    Kallur T; Blomberg P; Stenfelt S; Tryggvason K; Hovatta O
    Methods Mol Biol; 2017; 1590():11-16. PubMed ID: 28353259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Can cord blood banks transform into induced pluripotent stem cell banks?
    Zhou H; Rao MS
    Cytotherapy; 2015 Jun; 17(6):756-764. PubMed ID: 25770678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent progress of national banking project on homozygous HLA-typed induced pluripotent stem cells in South Korea.
    Rim YA; Park N; Nam Y; Ham DS; Kim JW; Ha HY; Jung JW; Jung SM; Baek IC; Kim SY; Kim TG; Song J; Lee J; Park SH; Chung NG; Yoon KH; Ju JH
    J Tissue Eng Regen Med; 2018 Mar; 12(3):e1531-e1536. PubMed ID: 28941241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Do human leukocyte antigen-typed cellular therapeutics based on induced pluripotent stem cells make commercial sense?
    Bravery CA
    Stem Cells Dev; 2015 Jan; 24(1):1-10. PubMed ID: 25244598
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Applications of induced pluripotent stem cell technologies in spinal cord injury.
    Nagoshi N; Okano H
    J Neurochem; 2017 Jun; 141(6):848-860. PubMed ID: 28199003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. cGMP-Manufactured Human Induced Pluripotent Stem Cells Are Available for Pre-clinical and Clinical Applications.
    Baghbaderani BA; Tian X; Neo BH; Burkall A; Dimezzo T; Sierra G; Zeng X; Warren K; Kovarcik DP; Fellner T; Rao MS
    Stem Cell Reports; 2015 Oct; 5(4):647-59. PubMed ID: 26411904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Considerations for the development of iPSC-derived cell therapies: a review of key challenges by the JSRM-ISCT iPSC Committee.
    Madrid M; Lakshmipathy U; Zhang X; Bharti K; Wall DM; Sato Y; Muschler G; Ting A; Smith N; Deguchi S; Kawamata S; Moore JC; Makovoz B; Sullivan S; Falco V; Al-Riyami AZ
    Cytotherapy; 2024 Nov; 26(11):1382-1399. PubMed ID: 38958627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcriptome Profiling Reveals Degree of Variability in Induced Pluripotent Stem Cell Lines: Impact for Human Disease Modeling.
    Schuster J; Halvardson J; Pilar Lorenzo L; Ameur A; Sobol M; Raykova D; Annerén G; Feuk L; Dahl N
    Cell Reprogram; 2015 Oct; 17(5):327-37. PubMed ID: 26348590
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of Integrating and Non-Integrating Reprogramming Methods on Copy Number Variation and Genomic Stability of Human Induced Pluripotent Stem Cells.
    Kang X; Yu Q; Huang Y; Song B; Chen Y; Gao X; He W; Sun X; Fan Y
    PLoS One; 2015; 10(7):e0131128. PubMed ID: 26131765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Addressing Manufacturing Challenges for Commercialization of iPSC-Based Therapies.
    Dashtban M; Panchalingam KM; Shafa M; Ahmadian Baghbaderani B
    Methods Mol Biol; 2021; 2286():179-198. PubMed ID: 32430594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantifying signaling pathway activation to monitor the quality of induced pluripotent stem cells.
    Makarev E; Fortney K; Litovchenko M; Braunewell KH; Zhavoronkov A; Atala A
    Oncotarget; 2015 Sep; 6(27):23204-12. PubMed ID: 26327604
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Korea National Stem Cell Bank.
    Kim JH; Jo HY; Ha HY; Kim YO
    Stem Cell Res; 2021 May; 53():102270. PubMed ID: 33714852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Report of the International Stem Cell Banking Initiative Workshop Activity: Current Hurdles and Progress in Seed-Stock Banking of Human Pluripotent Stem Cells.
    Kim JH; Kurtz A; Yuan BZ; Zeng F; Lomax G; Loring JF; Crook J; Ju JH; Clarke L; Inamdar MS; Pera M; Firpo MT; Sheldon M; Rahman N; O'Shea O; Pranke P; Zhou Q; Isasi R; Rungsiwiwut R; Kawamata S; Oh S; Ludwig T; Masui T; Novak TJ; Takahashi T; Fujibuchi W; Koo SK; Stacey GN
    Stem Cells Transl Med; 2017 Nov; 6(11):1956-1962. PubMed ID: 29067781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Banking on iPSC--is it doable and is it worthwhile.
    Solomon S; Pitossi F; Rao MS
    Stem Cell Rev Rep; 2015 Feb; 11(1):1-10. PubMed ID: 25516409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Banking human induced pluripotent stem cells: lessons learned from embryonic stem cells?
    Stacey GN; Crook JM; Hei D; Ludwig T
    Cell Stem Cell; 2013 Oct; 13(4):385-8. PubMed ID: 24094320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generating patient-specific induced pluripotent stem cells-derived cardiomyocytes for the treatment of cardiac diseases.
    Jeziorowska D; Korniat A; Salem JE; Fish K; Hulot JS
    Expert Opin Biol Ther; 2015; 15(10):1399-409. PubMed ID: 26134098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Granulosa cell-derived induced pluripotent stem cells exhibit pro-trophoblastic differentiation potential.
    Chuang CY; Huang MC; Chen HF; Tseng LH; Yu CY; Stone L; Huang HP; Ho HN; Kuo HC
    Stem Cell Res Ther; 2015 Feb; 6(1):14. PubMed ID: 25889179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.